These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27396431)

  • 1. Differential Regulation of Plasma Copeptin Levels in Patients with Heart Failure: A Single-Center Prospective Study.
    Iwashita N; Nara N; Sato R; Nakatogawa T; Kobayashi S; Zama S; Mita M; Hishinuma S; Shoji M
    Tohoku J Exp Med; 2016 Jul; 239(3):213-21. PubMed ID: 27396431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copeptin as a biomarker in heart failure.
    Balling L; Gustafsson F
    Biomark Med; 2014; 8(6):841-54. PubMed ID: 25224940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Plasma Copeptin Levels during Hemodialysis: Are the Physiological Stimuli Active in Hemodialysis Patients?
    Ettema EM; Kuipers J; Assa S; Bakker SJ; Groen H; Westerhuis R; Gaillard CA; Gansevoort RT; Franssen CF
    PLoS One; 2015; 10(5):e0127116. PubMed ID: 25973954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender and renal function influence plasma levels of copeptin in healthy individuals.
    Bhandari SS; Loke I; Davies JE; Squire IB; Struck J; Ng LL
    Clin Sci (Lond); 2009 Feb; 116(3):257-63. PubMed ID: 18647134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
    Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copeptin levels and invasive hemodynamics in patients with advanced heart failure.
    Balling L; Goetze JP; Jung MH; Rossing K; Boesgaard S; Gustafsson F
    Biomark Med; 2018 Aug; 12(8):861-870. PubMed ID: 30058349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.
    Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
    JAMA; 2011 May; 305(20):2088-95. PubMed ID: 21610241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction.
    Pozsonyi Z; Förhécz Z; Gombos T; Karádi I; Jánoskuti L; Prohászka Z
    Heart Lung Circ; 2015 Apr; 24(4):359-67. PubMed ID: 25618448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma copeptin, the c-terminal portion of arginine vasopressin during water deprivation and excess in healthy subjects.
    Szinnai G; Morgenthaler NG; Berneis K; Struck J; Müller B; Keller U; Christ-Crain M
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3973-8. PubMed ID: 17635944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.
    Zabarovskaja S; Hage C; Gabrielsen A; Mellbin L; Lund LH
    Heart Lung Circ; 2017 Feb; 26(2):143-149. PubMed ID: 27523461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of hyponatremia and elevated copeptin with death and need for transplantation in ambulatory patients with chronic heart failure.
    Miller WL; Grill DE; Struck J; Jaffe AS
    Am J Cardiol; 2013 Mar; 111(6):880-5. PubMed ID: 23276468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of copeptin for predicting long-term clinical outcomes in patients with heart failure.
    Yoshikawa Y; Shiomi H; Kuwahara K; Sowa N; Yaku H; Yamashita Y; Tazaki J; Imai M; Kato T; Saito N; Shizuta S; Ono K; Kimura T
    J Cardiol; 2019 May; 73(5):379-385. PubMed ID: 30591319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
    Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
    Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of copeptin, the stable peptide of the vasopressin precursor, in the differential diagnosis of sodium imbalance in patients with acute diseases.
    Nigro N; Müller B; Morgenthaler N; Fluri F; Schütz P; Neidert S; Stolz D; Bingisser R; Tamm M; Christ-Crain M; Katan M
    Swiss Med Wkly; 2011; 141():w13270. PubMed ID: 21990032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.
    Stoiser B; Mörtl D; Hülsmann M; Berger R; Struck J; Morgenthaler NG; Bergmann A; Pacher R
    Eur J Clin Invest; 2006 Nov; 36(11):771-8. PubMed ID: 17032344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma copeptin levels and prediction of outcome in heart failure outpatients: relation to hyponatremia and loop diuretic doses.
    Balling L; Kistorp C; Schou M; Egstrup M; Gustafsson I; Goetze JP; Hildebrandt P; Gustafsson F
    J Card Fail; 2012 May; 18(5):351-8. PubMed ID: 22555263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
    Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
    J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copeptin in heart failure: Review and meta-analysis.
    Zhong Y; Wang R; Yan L; Lin M; Liu X; You T
    Clin Chim Acta; 2017 Dec; 475():36-43. PubMed ID: 28982590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.